Thomas Chloe N, Berry Martin, Logan Ann, Blanch Richard J, Ahmed Zubair
Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK.
Cell Death Discov. 2017 Jul 3;3:17032. doi: 10.1038/cddiscovery.2017.32. eCollection 2017.
Retinal ganglion cells (RGC) are terminally differentiated CNS neurons that possess limited endogenous regenerative capacity after injury and thus RGC death causes permanent visual loss. RGC die by caspase-dependent mechanisms, including apoptosis, during development, after ocular injury and in progressive degenerative diseases of the eye and optic nerve, such as glaucoma, anterior ischemic optic neuropathy, diabetic retinopathy and multiple sclerosis. Inhibition of caspases through genetic or pharmacological approaches can arrest the apoptotic cascade and protect a proportion of RGC. Novel findings have also highlighted a pyroptotic role of inflammatory caspases in RGC death. In this review, we discuss the molecular signalling mechanisms of apoptotic and inflammatory caspase responses in RGC specifically, their involvement in RGC degeneration and explore their potential as therapeutic targets.
视网膜神经节细胞(RGC)是终末分化的中枢神经系统神经元,损伤后其自身再生能力有限,因此RGC死亡会导致永久性视力丧失。在发育过程中、眼部受伤后以及在眼部和视神经的进行性退行性疾病(如青光眼、前部缺血性视神经病变、糖尿病性视网膜病变和多发性硬化症)中,RGC通过包括凋亡在内的半胱天冬酶依赖性机制死亡。通过基因或药理学方法抑制半胱天冬酶可以阻止凋亡级联反应,并保护一部分RGC。新的研究结果还突出了炎症性半胱天冬酶在RGC死亡中的焦亡作用。在这篇综述中,我们具体讨论RGC中凋亡和炎症性半胱天冬酶反应的分子信号机制、它们在RGC变性中的作用,并探索它们作为治疗靶点的潜力。